Showing posts with label Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions. Show all posts
Showing posts with label Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions. Show all posts
Thursday, April 19, 2018

FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions

›
  In continuation of my update on amantadine Osmotica Pharmaceutical US LLC, announced the  U.S. Food and Drug Administration ...